Skip to main content
T

Transgene Biotek Ltd. — Investor Relations & Filings

Ticker · 526139 ISIN · INE773D01018 BSE.NS Professional, scientific and technical activities
Filings indexed 0 across all filing types
Latest filing no filings yet
Country IN India
Listing BSE.NS 526139

About Transgene Biotek Ltd.

https://www.transgenebiotek.com/

Transgene Biotek Ltd. focuses on the research and development of therapeutic solutions within the life sciences sector. The company specializes in oncology, RNA interference (RNAi) technology, and advanced drug delivery systems. Its research portfolio includes the development of monoclonal antibodies, vaccines, and biogenerics designed to treat complex medical conditions. A core technological focus is the Trabi-ORAL platform, which facilitates the oral delivery of proteins and peptides, including insulin. The company advances therapeutic candidates from discovery through clinical development, aiming to provide innovative treatments for chronic diseases and improve patient outcomes through specialized medical research.

Recent filings

No filings indexed yet

We are still gathering filings for Transgene Biotek Ltd.. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.